{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:41:14Z","timestamp":1773272474828,"version":"3.50.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/cmr.0b013e3282f32517","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:00:15Z","timestamp":1236258015000},"page":"29-35","source":"Crossref","is-referenced-by-count":67,"title":["Mutation analysis of the EGFR\u2013NRAS\u2013BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Lars A.","family":"Akslen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Puntervoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg M.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oddbj\u00f8rn","family":"Straume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edda","family":"Vuhahula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Molven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"R2-5-20210129","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma","volume":"62","author":"Brose","year":"2002","journal-title":"Cancer Res"},{"key":"R3-5-20210129","first-page":"3883","article-title":"BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma","volume":"63","author":"Dong","year":"2003","journal-title":"Cancer Res"},{"key":"R4-5-20210129","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.0022-202x.2001.01601.x","article-title":"Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma","volume":"117","author":"Demunter","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R7-5-20210129","first-page":"3468","article-title":"Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression","volume":"8","author":"Omholt","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3163-3-6","article-title":"Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis","volume":"3","author":"Houben","year":"2004","journal-title":"J Carcinog"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1167\/iovs.02-1329","article-title":"Lack of BRAF mutation in primary uveal melanoma","volume":"44","author":"Cohen","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-5-20210129","first-page":"5761","article-title":"Absence of BRAF and NRAS mutations in uveal melanoma","volume":"63","author":"Cruz","year":"2003","journal-title":"Cancer Res"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.bjc.6600919","article-title":"Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas","volume":"88","author":"Edmunds","year":"2003","journal-title":"Br J Cancer"},{"key":"R14-5-20210129","first-page":"5712","article-title":"Lack of BRAF mutations in uveal melanoma","volume":"63","author":"Rimoldi","year":"2003","journal-title":"Cancer Res"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas","volume":"41","author":"Edwards","year":"2004","journal-title":"J Med Genet"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.2004.022509","article-title":"BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs","volume":"58","author":"Wong","year":"2005","journal-title":"J Clin Pathol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","author":"Jorissen","year":"2003","journal-title":"Exp Cell Res"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u2018never smokers\u2019 and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(04)15649-3","article-title":"Is there more than one road to melanoma?","volume":"363","author":"Rivers","year":"2004","journal-title":"Lancet"},{"key":"R23-5-20210129","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.0022-202X.2005.23788.x","article-title":"BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival","volume":"125","author":"Akslen","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00428-006-0191-8","article-title":"Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes","volume":"448","author":"Immervoll","year":"2006","journal-title":"Virchows Arch"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/bbrc.2000.2716","article-title":"Melanin binds reversibly to thermostable DNA polymerase and inhibits its activity","volume":"271","author":"Eckhart","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1038\/sj.onc.1206909","article-title":"Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9","volume":"22","author":"Kumar","year":"2003","journal-title":"Oncogene"},{"key":"R28-5-20210129","first-page":"3362","article-title":"BRAF mutations in metastatic melanoma: a possible association with clinical outcome","volume":"9","author":"Kumar","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0002-9440(10)64922-X","article-title":"Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor\/fibroblast growth factor receptor-1 and Ephrin-A1\/EphA2 on melanoma progression","volume":"160","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.154.11.1","article-title":"Increased vascularization predicts favorable outcome in follicular lymphoma","volume":"11","author":"Koster","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bjc.1996.172","article-title":"Breast cancer incidence subsequent to surgical reduction of the female breast","volume":"73","author":"Baasch","year":"1996","journal-title":"Br J Cancer"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5","article-title":"Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma","volume":"74","author":"Straume","year":"1997","journal-title":"Int J Cancer"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.1127515","article-title":"MC1R germline variants confer risk for BRAF-mutant melanoma","volume":"313","author":"Landi","year":"2006","journal-title":"Science"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","article-title":"Melanoma and sun exposure: an overview of published studies","volume":"73","author":"Elwood","year":"1997","journal-title":"Int J Cancer"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1200\/JCO.2006.06.1325","article-title":"Anatomic site, sun exposure, and risk of cutaneous melanoma","volume":"24","author":"Whiteman","year":"2006","journal-title":"J Clin Oncol"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199904293401707","article-title":"The pathogenesis of melanoma induced by ultraviolet radiation","volume":"340","author":"Gilchrest","year":"1999","journal-title":"N Engl J Med"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjc.1979.165","article-title":"Racial differences in melanoma incidence","volume":"40","author":"Crombie","year":"1979","journal-title":"Br J Cancer"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.0022-202X.2004.22523.x","article-title":"Tandem BRAF Mutations in Primary Invasive Melanomas","volume":"122","author":"Thomas","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/nar\/gkf478","article-title":"Oxidative DNA damage induced by copper and hydrogen peroxide promotes CGTT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells","volume":"30","author":"Lee","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.onc.1209379","article-title":"Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma","volume":"25","author":"Sensi","year":"2006","journal-title":"Oncogene"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.0022-202X.2004.22225.x","article-title":"BRAF mutations are common somatic events in melanocytic nevi","volume":"122","author":"Kumar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1034\/j.1600-0749.2003.08330.x","article-title":"SP-11 Different frequencies of a BRAF point mutation in melanocytic skin lesions","volume":"16","author":"Yazdi","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1523-1747.2003.12559.x","article-title":"Mutations of the BRAF gene in benign and malignant melanocytic lesions","volume":"121","author":"Yazdi","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.jid.5700490","article-title":"Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations","volume":"127","author":"Bauer","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1440-0960.1999.00310.x","article-title":"Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization","volume":"40","author":"Sparrow","year":"1999","journal-title":"Australas J Dermatol"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0625.2001.100504.x","article-title":"Regulation of epidermal growth factor receptor expression in human melanocytes","volume":"10","author":"Gordon-Thomson","year":"2001","journal-title":"Exp Dermatol"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008390-200502000-00005","article-title":"ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells","volume":"15","author":"Gordon-Thomson","year":"2005","journal-title":"Melanoma Res"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.onc.1208125","article-title":"Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway","volume":"24","author":"Ivanov","year":"2005","journal-title":"Oncogene"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archderm.140.7.819","article-title":"UV radiation, latitude, and melanoma in US Hispanics and blacks","volume":"140","author":"Hu","year":"2004","journal-title":"Arch Dermatol"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1008872014889","article-title":"A case\u2013control study of melanomas of the soles and palms (Australia and Scotland)","volume":"10","author":"Green","year":"1999","journal-title":"Cancer Causes Control"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008390-200802000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:24:20Z","timestamp":1710127460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-200802000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e3282f32517","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}